IGM Biosciences Inc (IGMS)
10.35
-0.87
(-7.75%)
USD |
NASDAQ |
Nov 14, 12:58
IGM Biosciences Market Cap: 613.95M for Nov. 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 665.56M |
| November 12, 2024 | 673.27M |
| November 11, 2024 | 764.02M |
| November 08, 2024 | 772.92M |
| November 07, 2024 | 852.41M |
| November 06, 2024 | 864.87M |
| November 05, 2024 | 939.02M |
| November 04, 2024 | 930.71M |
| November 01, 2024 | 962.15M |
| October 31, 2024 | 1.017B |
| October 30, 2024 | 1.044B |
| October 29, 2024 | 1.024B |
| October 28, 2024 | 1.058B |
| October 25, 2024 | 998.93M |
| October 24, 2024 | 939.61M |
| October 23, 2024 | 950.88M |
| October 22, 2024 | 1.035B |
| October 21, 2024 | 929.52M |
| October 18, 2024 | 991.81M |
| October 17, 2024 | 950.88M |
| October 16, 2024 | 840.55M |
| October 15, 2024 | 915.29M |
| October 14, 2024 | 996.55M |
| October 11, 2024 | 889.78M |
| October 10, 2024 | 823.94M |
| Date | Value |
|---|---|
| October 09, 2024 | 806.14M |
| October 08, 2024 | 863.09M |
| October 07, 2024 | 813.85M |
| October 04, 2024 | 914.10M |
| October 03, 2024 | 883.85M |
| October 02, 2024 | 854.19M |
| October 01, 2024 | 860.12M |
| September 30, 2024 | 981.13M |
| September 27, 2024 | 1.008B |
| September 26, 2024 | 940.79M |
| September 25, 2024 | 973.42M |
| September 24, 2024 | 1.002B |
| September 23, 2024 | 948.51M |
| September 20, 2024 | 958.59M |
| September 19, 2024 | 1.022B |
| September 18, 2024 | 987.66M |
| September 17, 2024 | 1.049B |
| September 16, 2024 | 939.61M |
| September 13, 2024 | 729.62M |
| September 12, 2024 | 675.64M |
| September 11, 2024 | 696.40M |
| September 10, 2024 | 668.52M |
| September 09, 2024 | 609.20M |
| September 06, 2024 | 552.26M |
| September 05, 2024 | 608.02M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
230.04M
Minimum
Oct 31 2023
3.876B
Maximum
Feb 09 2021
1.230B
Average
895.93M
Median
Dec 02 2022
Market Cap Benchmarks
| Moderna Inc | 16.04B |
| NovaBay Pharmaceuticals Inc | 3.466M |
| Palatin Technologies Inc | 20.53M |
| iBio Inc | 19.69M |
| Theriva Biologics Inc | 1.407M |
Market Cap Related Metrics
| PS Ratio | 213.36 |
| Price to Book Value | 5.018 |
| Price | 10.35 |
| Earnings Yield | -35.17% |